Loading...
23 items
2026-10-06
From July 31, 2026 to September 30, 2026, the company has repurchased 71,000 shares, representing 0.52% for ¥212.5 million. With this, the company has completed the repurchase of 71,000 shares, representing 0.52% for ¥212.5 million under the buyback announced on July 31, 2026.
2026-09-23
Ishihara Chemical Co., Ltd.(TSE:4462) added to S&P Global BMI Index
2026-08-28
Ishihara Chemical Co., Ltd. reported earnings results for the first quarter ended June 30, 2026. For the first quarter, the company reported sales was JPY 6,281 million. Net income was JPY 841 million. Basic earnings per share from continuing operations was JPY 61.59.
2026-08-01
Ishihara Chemical Co., Ltd. provided Consolidated earnings guidance for the six months ending September 30, 2026 and full year ending March 31, 2027. For the six months ending September 30, 2026, the company expects net sales of JPY 12,400 million, operating profit of JPY 1,960 million, Profit attributable to owners of parent of JPY 1,440 million. Basic earnings per share of JPY 105.34. For the full year ending March 31, 2027, the company expects net sales of JPY 25,600 million, operating profit of JPY 3,760 million, Profit attributable to owners of parent of JPY 2,760 million. Basic earnings per share of JPY 201.86.
2026-08-01
Ishihara Chemical Co., Ltd., Board Meeting, Jul 31, 2026. Agenda: To consider the matters concerning the acquisition of treasury shares pursuant to the provisions of Article 156 of the Companies Act, as applied by replacing the relevant terms pursuant to the provisions of Article 165, paragraph (3) of the same Act.
2026-07-31
The Board of Directors of Ishihara Chemical Co., Ltd. has authorized a buyback plan on July 31, 2026.
2026-07-31
Ishihara Chemical Co., Ltd. (TSE:4462) announces a share repurchase program. Under the program, the company will repurchase up to 300,000 shares, representing 2.2% of its issued share capital for ¥1,000 million. The purpose of the program is to enhance shareholder returns, improve capital efficiency, and implement a flexible capital policy in response to changes in the business environment. The program is valid till March 31, 2027. As of June 30, 2026, the company had 13,665,504 shares issued (excluding treasury stock) and 1,488,176 shares in treasury.
2026-07-24
Ishihara Chemical Co., Ltd., ¥ 24.0, Cash Dividend, Sep-29-2026
2026-06-25
Ishihara Chemical Co., Ltd., Board Meeting, Jun 25, 2026. Agenda: To consider and approve the disposal of treasury shares as restricted stock compensation.
2026-06-09
Ishihara Chemical Co., Ltd. provided Consolidated earnings guidance for the six months ending September 30, 2026 and full year ending March 31, 2027. For the six months ending September 30, 2026, the company expects net sales of JPY 12,400 million, operating profit of JPY 1,960 million, Profit attributable to owners of parent of JPY 1,440 million. Basic earnings per share of JPY 105.37. For the full year ending March 31, 2027, the company expects net sales of JPY 25,600 million, operating profit of JPY 3,760 million, Profit attributable to owners of parent of JPY 2,760 million. Basic earnings per share of JPY 201.97.
2026-05-15
Ishihara Chemical Co., Ltd., Annual General Meeting, Jun 25, 2026.
2026-05-15
Ishihara Chemical Co., Ltd., Board Meeting, May 14, 2026. Agenda: To consider Continuation of Policy in Response to Large-Scale Purchases of the Company's Shares.
2026-05-09
Ishihara Chemical Co., Ltd. announced that they will report fiscal year 2026 results on May 15, 2026
2026-05-09
Ishihara Chemical Co., Ltd. announced that they will report Q1, 2027 results on Jul 31, 2026
2026-03-17
ISHIHARA CHEMICAL CO., LTD. resolved at the Board of Directors meeting held on March 13, 2026, to change its director (scheduled for April 1,2026). Shoya Iuchi will assume the position of Managing Director, Chief Technology Officer and Chairman of ISHIHARA CHEMICAL(SHANGHAI)CO., LTD. and Director of ISHIHARA CHEMICAL(SHANGHAI)TECHNOLOGY CO., LTD., effective April 1, 2026. Shoya Iuchi currently serves as Director, Chief Technology Officer and General Manager of Second Research&Development Department and Chairman of ISHIHARA CHEMICAL(SHANGHAI)CO., LTD. and Director of ISHIHARA CHEMICAL(SHANGHAI)TECHNOLOGY CO., LTD.
2026-03-13
Ishihara Chemical Co., Ltd., Board Meeting, Mar 13, 2026. Agenda: To consider Change in Directors.
2026-02-03
Ishihara Chemical Co., Ltd. reported earnings results for the nine months ended December 31, 2025. For the nine months, the company reported sales was JPY 17,498.16 million compared to JPY 18,008.4 million a year ago. Net income was JPY 2,064.88 million compared to JPY 2,001.74 million a year ago. Basic earnings per share from continuing operations was JPY 151.14 compared to JPY 138.99 a year ago.
2026-01-30
Ishihara Chemical Co., Ltd. expected to report Fiscal Year 2026 results on May 15, 2026. This event was calculated by S&P Global (Created on January 30, 2026).
2025-12-11
Ishihara Chemical Co., Ltd., Board Meeting, Dec 11, 2025. Agenda: To consider Changes in Directors' Responsibilities.
2025-11-03
Ishihara Chemical Co., Ltd. announced second quarter-end dividend for fiscal year ending March 31, 2026. For the period, the company announced a dividend of JPY 22.00 per share against JPY 20.00 per share a year ago. Scheduled date to commencing dividend payments: December 1, 2025.
2025-11-03
Ishihara Chemical Co., Ltd. provided consolidated earnings guidance for the Year Ending March 31, 2026. For the period, the company expects net sales of JPY 24,500 million, operating profit of JPY 3,510 million, Profit attributable to owners of parent of JPY 2,550 million. Basic earnings per share of JPY 186.64.
2025-10-31
Ishihara Chemical Co., Ltd., ¥ 22.0, Cash Dividend, Mar-30-2026
2025-10-31
ISHIHARA CHEMICAL CO., LTD. announced that it has established an overseas subsidiary in China, as ISHIHARA CHEMICAL (SHANGHAI) TECHNOLOGY CO., LTD. Purpose of establishment: The Company has established an overseas subsidiary to build a stable product supply system within China and enable flexible responses to local needs. Overview of the subsidiary Location: No.1, 11th Building, No.39, Canghang Road, Fengxian District, Shanghai. Representative: Yutaka Tanida. Business details: Manufacture and sale of electronic-related chemical products. Capital: USD 5,000,000. Board resolution: June 19, 2025. Establishment: September 1, 2025. Fiscal year end: December 31. Ownership ratio: 100% owned by the Company. Start of operations: 2026 (scheduled). The impact on the Company's consolidated financial results for the fiscal year ending March 31, 2026, is expected to be immaterial.
2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 24,164 | 23,450 | 23,120 | 23,189 | 23,217 | 23,630 | 23,294 | 22,701 | 21,919 | 20,705 |
Pretax Income Excl.Unusual Items | 4,513 | 3,993 | 3,492 | 3,370 | 3,259 | 3,459 | 3,433 | 3,092 | 2,900 | 2,461 |
Total Assets | 30,901 | 30,009 | 28,367 | 28,245 | 26,935 | 26,997 | 26,376 | 28,541 | 28,204 | 27,918 |
Total Liabilities | 5,512 | 5,284 | 4,660 | 5,142 | 4,754 | 5,099 | 4,934 | 7,574 | 4,817 | 4,811 |
Cash & Cash Equivalents | 9,851 | 9,168 | 7,699 | 7,744 | 6,591 | 6,531 | 5,492 | 7,867 | 6,261 | 5,652 |
Total Common Equity | 25,389 | 24,725 | 23,707 | 23,103 | 22,180 | 21,898 | 21,442 | 20,968 | 23,387 | 23,107 |
Book Value Per Share (BVPS) | 1,857.89 | 1,809.29 | 1,734.78 | 1,690.59 | 1,624.03 | 1,603.37 | 1,569.99 | 1,439.35 | 1,573.34 | 1,545.61 |
Net Change in Cash | 2,636 | -88 | 105 | 2,087 | 689 | |||||
Capital Expenditure | -639 | -588 | -389 | -592 | -688 |
As of July 31, 2026, Ishihara Chemical published financial results for the second quarter of 2026, with revenues of 6.28B yen and net income of 841M yen, representing a revenue increase of 12.8%, coupled with a substantial increase of about 83.4% in EPS relative to the corresponding quarter last year.
Moreover, the EBITDA margin witnessed a sharp rise from 13.79% in the same quarter last year to 20%. This increase is usually indicative of the company raising prices or implementing optimization techniques in its business sectors, leading to higher EBITDA margins and, consequently, improving the stock's performance in the future. and it trades at 13.7x times current year's earnings, which is higher than the sector average (P/E 10.8x).
